Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424665
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-12
Brief Title:
A Study of FZ-AD005 in Patients With Advanced Solid Tumors
Sponsor:
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Organization:
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Study Overview
Official Title:
A Phaseâ… Study to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of FZ-AD005 in Patients With Advanced Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A First-in-Human Open Label Phase I Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Antitumor Activity of FZ-AD005 in Patients with Advanced Solid Tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None